Obesity Therapies, Monoclonal Antibody
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
48
NCT06845943
A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes
Phase: Early Phase 1
Role: Lead Sponsor
Start: Mar 4, 2025
Completion: Dec 31, 2025
Loading map...